SCHEMBL6633282

SCHEMBL6633282

CCOC(=O)Cn1c(COc2ccc(C#N)cc2)nc2ccc(NS(=O)(=O)CCCN(C)C)cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 3/20 0.39
CACNA1B Q00975 2/20 0.39
SCN9A Q15858 1/20 0.38
ALOX5AP P20292 3/20 0.38
MAPT P10636 4/20 0.37
NPC1 O15118 2/20 0.37
NLRP3 Q96P20 1/20 0.37
PPARG P37231 1/20 0.36
P2RX3 P56373 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
HSD17B10 Q99714 2/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BRD4 O60885 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6635781 0.94 MAPT (0.42) CACNA1HCACNA1BSCN9AALOX5APMAPT
SCHEMBL6640165 0.88 F10 (0.39) MAPTNPC1NLRP3NPSR1CNR2
SCHEMBL6634416 0.84 MAPT (0.36) CACNA1HCACNA1BALOX5APMAPTNPC1
SCHEMBL6635525 0.83 AR (0.48) ALOX5APMAPTNPSR1HTTMEN1
SCHEMBL6636378 0.82 F10 (0.43) MAPTNPC1NLRP3NPSR1CNR2
SCHEMBL6633284 0.81 ALOX5AP (0.39) SCN9AALOX5APMAPTNPC1NLRP3
SCHEMBL6642040 0.79 F10 (0.44) MEN1KMT2A
SCHEMBL6639192 0.79 MAPT (0.40) CACNA1HCACNA1BALOX5APMAPTNPC1
SCHEMBL6634421 0.78 HCRTR2 (0.39) ALOX5APMAPTNPC1NLRP3PPARG
SCHEMBL6633348 0.78 PPARG (0.48) ALOX5APMAPTNPC1NLRP3PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1100795-B1 DISUBSTITUTED BICYCLIC HETEROCYCLES HAVING, IN PARTICULAR, A THROMBIN INHIBITIVE EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2004-06-09 EP disclosed
US-6121308-A INDOLE AND BENZIMIDAZOLE ANTITHROMBOTIC COMPOUNDS, SUCH AS 1-METHYL-2-(N-(4-AMIDINOPHENYL)-AMINOMETHYL)-5-(N-(HYDROXYCARBONYLMETHYL) -QUINOLINE-8-SULPHONYLAMINO)-INDOLE BOEHRINGER INGELHEIM KG (DE) 2000-09-19 US disclosed